A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica

OBJECTIVE: As phase III trials have shown interest in innovative but expensive drugs in the treatment of neuromyelitis optica spectrum disorder (NMOSD), data are needed to clarify strategies in the treatment of neuromyelitis optica (NMO). This meta‐analysis compares the efficacy of first‐line strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannelli, Jonathan, Ciron, Jonathan, Cohen, Mikael, Kim, Ho‐Jin, Kim, Su‐Hyun, Stellmann, Jan‐Patrik, Kleiter, Ingo, McCreary, Morgan, Greenberg, Benjamin M., Deschamps, Romain, Audoin, Bertrand, Maillart, Elisabeth, Papeix, Caroline, Collongues, Nicolas, Bourre, Bertrand, Laplaud, David, Ayrignac, Xavier, Durand‐Dubief, Françoise, Ruet, Aurélie, Vukusic, Sandra, Marignier, Romain, Dauchet, Luc, Zephir, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528466/
https://www.ncbi.nlm.nih.gov/pubmed/34505407
http://dx.doi.org/10.1002/acn3.51451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528466/
https://www.ncbi.nlm.nih.gov/pubmed/34505407
http://dx.doi.org/10.1002/acn3.51451

Ejemplares similares